Protheragen, a leading biotechnology company specializing in advanced research services, announces its comprehensive suite of solutions designed to accelerate research and treatment development for Systemic Mitochondrial Disease. The company's specialized services address the complex

Protheragen, a leading biotechnology company specializing in innovative genetic solutions, announced the expansion of its comprehensive Adeno-Associated Virus (AAV) Vector Platform services to meet the growing demands of gene therapy research and development.